The King Hussein Cancer Foundation (KHCF) and King Hussein Cancer Center (KHCC) are pleased to announce that the partnership between the Stavros Niarchos Foundation (SNF) and KHCF, which began in 2022, has been renewed for another two years. SNF’s new grant aims to support cancer treatment and care for disadvantaged children from across the Middle East at KHCC.
SNF renews its support to KHCF
17 February 2025
This renewal follows a grant SNF made to KHCF in 2022, which helped cover treatment costs for 125 underprivileged children of varying ages and backgrounds from across the region at KHCC.
HRH Princess Ghida, Chairperson of KHCF and KHCC stated: “We are immensely proud of the King Hussein Cancer Foundation and Center’s partnership with the Stavros Niarchos Foundation, which stands as a testament to the life-saving impact of international collaboration in the fight against cancer.”
Quality cancer care should be available to every child who needs it, full stop.
Andreas Dracopoulos, SNF Co-President
SNF Co-President Andreas Dracopoulos said: “Quality cancer care should be available to every child who needs it, full stop. This means allowing ourselves to be guided by future possibilities for care rather than past patterns of access. In providing care to kids across the region who otherwise would not have access, this is exactly what King Hussein Cancer Center is doing, and we are very proud to renew our support as part of SNF’s Global Health Initiative (GHI).”
These grants to KHCF/KHCC are part of SNF’s ongoing Global Health Initiative (GHI), its largest-ever grant initiative. The GHI includes the design, construction and outfitting of three new hospitals in Greece, procurement of critical equipment such as air ambulances, training programs for health care providers, efforts to expand access to quality mental health care such as the Child and Adolescent Mental Health Initiative in Greece, and collaborations with global institutions like The Rockefeller University, Columbia University, NewYork-Presbyterian Hospital, the Child Mind Institute, and Memorial Sloan Kettering Cancer Center in the United States; Sant Joan de Déu Barcelona Children’s Hospital in Spain; and Yorkshire Cancer Research in the United Kingdom.